Accepted at 5:55 p.m. Apr, 19, 2025 by Ahmed7
Author: docox123
Related Note: 1484188868232 1
Rationale for change

added nbme12 tags, card directly helps answer the Q:

A 15-year-old girl is brought to the office for a well-child examination. She has no history of serious illness and takes no medications. Her temperature is36.9°C (98.4°F), pulse is 86/min, respirations are 16/min, and blood pressure is 100/60 mm Hg. A photograph of the back is shown. The remainder of the examination shows no abnormalities. In addition to routine annual growth and development assessments, which of the following is the most appropriate recommendation regarding routine screening in this patient?

Ans: Yearly ophtalmologic exams
Explanation: Neurofibromatosis type 1 is an autosomal dominant neurocutaneous disorder that presents with cutaneous neurofibromas, cafe-au-lait spots, axillary or inguinal freckling, pigmented iris hamartomas (eg, Lisch nodules), optic pathway gliomas (OPGs), and/or pheochromocytomas. Annual screening is multidisciplinary and includes ophthalmic screening to detect OPGs.

Text
Extra
Lecture Notes
Empty field
Missed Questions
Empty field
Pathoma
Empty field
Boards and Beyond
Empty field
First Aid
Sketchy
Sketchy 2
Empty field
Sketchy Extra
Empty field
Picmonic
Empty field
Pixorize
Physeo
Empty field
Bootcamp
Empty field
OME
Additional Resources
One by one
Empty field
Changed Tags
#AK_Step2_v12::#NBME::Form12
#AK_Step1_v12::#AMBOSS::e3axh4 #AK_Other::#AK_Original_Decks::Step_1::Zanki_Step_Decks::Zanki_Neurology::Neuro_Misc #AK_Step2_v12::#NBME::Form14::Section_4 #AK_Step2_v12::#UWorld::Step::2669 #AK_Step2_v12::#Resources_by_rotation::Peds::uworld::neuro::neuro_zanki #AK_Step2_v12::#FirstAid::09_Neuro::15_Neurocutaneous_Disorders::01_Neurofibromatosis #AK_Step1_v12::#OME::Clinical::Neurology #AK_Step1_v12::#FirstAid::12_Neurology_and_Special_Senses::03_Pathology::25_Neurocutaneous_disorders::*Neurofibromatosis_1 #AK_Step2_v12::#UWorld::COMLEX::100351 #AK_Step3_v12::#UWorld::5110 #AK_Step1_v12::#SketchyPath::13_Neuro::04_Congenital_&_Neurocutaneous::03_Neurofibromatosis #AK_Step2_v12::!Shelf::Peds::no_dupes #AK_Step2_v12::#UWorld::COMLEX::28481 #AK_Step2_v12::Original_decks::Zanki_Step_2::Peds::Neuro #AK_Step2_v12::#UWorld::Step::3550 #AK_Step1_v12::^Systems::Neuro::neurology #AK_Other::!AK_UpdateTags::AnKing_Image::!Subjects::Neurology::Neurofibromatosis_1 #AK_Step1_v12::#Low/HighYield::2-RelativelyHighYield #AK_Step1_v12::#B&B::08_Derm::01_General::11_Neurocutaneous_Disorders #AK_Step1_v12::#Physeo::05_Biochem::04_Genetics::06_Autosomal_Dominant_Diseases_-_Part_1 #AK_Step2_v12::#AMBOSS::Pw0WQR #AK_Other::!AK_UpdateTags::AnKing_Image::AhmedA::Neurofibromatosis_1 #AK_Step2_v12::#UWorld::COMLEX::100839 #AK_Step2_v12::#UWorld::Step::4049 #AK_Step1_v12::#Physeo::11_Pathology::05_Neuropathology_Pathology::09_Neurocutaneous_Disorders #AK_Step1_v12::^Systems::Neuro::Pathology #AK_Step2_v12::#AMBOSS::Lo0wcS #AK_Step1_v12::#Pixorize::01_Biochemistry::05_Autosomal_Dominant_Diseases::10_Von_Recklinghausen_Disease_(NF_I)